Healthcare

The target size for Audax Private Equity Fund VIII represents a 19% increase from capital raised by its 2023-vintage predecessor.

The lower mid-market is ‘structurally superior to the upper mid-market/mega-cap private equity market,’ managing partner Rob Wolfson told Buyouts.

Healthcare’s growth potential and breadth of underlying sub-sectors are driving secondaries activity in the industry, says Linden Capital Partners’ Tony Davis.

Lower valuations, corporate carve-outs and resilience to AI disruption are opening up medtech to buyout firms after years of limited access.

Predictable revenues are attracting private equity investors to the sector.

Population changes, sectoral fragmentation and rising spending are creating an opening for private equity in payer services.

Nihon PMI’s 2022-vintage Fund I has already delivered a more than 1x DPI, PEI understands.

Industrials, defence and healthcare sectors stand to benefit, co-head of Americas PE Steve Wise tells PEI.

'Our top priority is positioning HPC for its next phase of growth,' William Sonneborn tells Buyouts.

The sovereign fund can write tickets up to $2bn per transaction, Josh Zhou, head of healthcare private equity for North America, tells PEI.